Featured patents

Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
US 08835398 B2, Sept. 16, 2014, Polynucleotide, Michael Peled et al. / Vascular Biogenics Ltd. (Or Yehuda, IL)
A method of inhibiting angiogenesis in an endothelial tissue of a subject in need…

Pest Control Composition
US 08796231 B2, Aug. 5, 2014, The hetero ring has 8 or more ring carbons, Yasutaka Shimokawatoko et al. / Sumitomo Chemical Company, Limited (Tokyo, JP)
A pest control composition comprising etoxazole and a compound represented by…

Branched PEG Remodeling and Glycosylation of Glucagon-Like Peptide-1 [GLP-1]
US 08791066 B2, July 29, 2014, Glucagon, glucagon-like peptide or derivative affecting or utilizing, Shawn DeFrees / Novo Nordisk A/S (Bagsvaerd, DK)
A mutant glucagon-like peptide-1 (GLP-1)-glucagon-like peptide-2 (GLP-2) fusion…

Pyrrolidine Triple Reuptake Inhibitors
US 08754117 B2, June 17, 2014, Additional hetero ring, Jianguo Ma et al. / Sunovion Pharmaceuticals Inc. (Marlborough, US)
A compound having a structure of formula (I) or a pharmaceutically acceptable…

2,5-Disubstituted Piperidine Orexin Receptor Antagonists
US 08710076 B2, April 29, 2014, Isoquinolines (including hydrogenated), Anthony J. Roecker et al. / Merck Sharp & Dohme Corp. (Rahway, US)
A compound of the formula Ia:…

Use of Phosphodiesterase Inhibitors for Treating Multidrug Resistance
US 08673914 B2, March 18, 2014, Polycyclo ring system having the hetero ring as one of the cyclos, Zhe-Sheng Chen et al. / St. John's University (Jamaica, US)
A method of treating multidrug resistance in a cancer cell in a subject in need…

Pharmaceutical Formulation Containing Choline Alfoscerate
US 08633176 B2, Jan. 21, 2014, Nitro group bonded to a carbon, Su-Jun Park et al. / CTC Bio, Inc. (Seoul, KR)
A pharmaceutical preparation comprising choline alfoscerate, wherein choline…

Soluble Guanylate Cyclase Activators
US 08569339 B2, Oct. 29, 2013, Isoquinolines (including hydrogenated), Jehrod Burnett Brenneman et al. / Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
A compound of the formula I…

Method for the Production of Conjugates of Insulin-Like Growth Factor-1 and Poly(ethylene Glycol)
US 08476232 B2, July 2, 2013, Insulin-like growth factor 1 (IGF-1) or derivative, Hendrik Knoetgen et al. / Hoffman-La Roche Inc. (Nutley, US)
The method of preparing lysine-PEGylated IGF-I or lysine-PEGylated IGF-I variant…

Compounds and Methods for Inhibiting the Interaction of BCL Proteins With Binding Partners
US 08461191 B2, June 11, 2013, 1,2-oxazoles (including hydrogenated), Brian T. Hopkins et al. / Infinity Pharmaceuticals, Inc. (Cambridge, US)
A method of treating cancer, comprising the step of administering to a patient…

Patentorg has 8391 documents under Drugs: Designated Organic Active Ingredient Containing Patents.

Narrow down the browsing criteria below to see more patents.

Select a subcategory
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot